Health officials warn of a preventable but potentially fatal lung disease linked to quartz countertops. Massachusetts reported its first silicosis case involved a stone worker.

A popular material for kitchen countertops has been linked to a life-threatening lung disease, silicosis. Health officials in Massachusetts just announced the first confirmed case in the stone countertop industry in the state. Cases of silicosis are increasing in the stone countertop industry.

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | Boehringer's Jascayd can now crack open the rare progressive pulmonary fibrosis disease market just two months after its initial market entry in idiopathic pulmonary fibrosis.

Dust from popular countertop material that causes incurable lung disease found in Massachusetts worker - The disease has previously resulted in dozens of deaths in California and across the country

Health officials confirmed Massachusetts’ first case of silicosis, an incurable and life-threatening lung disease, warning that this suggests that additional, unconfirmed cases could exist. The patient spent the past 14 years working for a stone countertop fabrication and installation company.

A 40-year-old Hispanic man from Massachusetts is the state's first confirmed case of silicosis from working with engineered stone countertops. He spent 14 years cutting, polishing, and installing these quartz-based surfaces.

"I have always hoped that we would be able to keep the disease in check with medication, and the development has actually been quite slow up until now," Crown Princess Mette-Marit shared.

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase 3 LATIFY trial versus standard-of-care docetaxel in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), according to a news release from AstraZeneca.

She was diagnosed with chronic lung disease in 2018.

Heart attacks, lung problems and other illnesses spiked within three months of the Los Angeles wildfires early this year, researchers said.